ACELER-CO

This brand name is authorized in Ecuador.

Active ingredients

The drug ACELER-CO contains a combination of these active pharmaceutical ingredients (APIs):

1	Fusidic acid UNII 59XE10C19C - FUSIDIC ACID
	Fusidic acid belongs to a unique group of antibiotics, the fusidanes, which act to inhibit bacterial protein synthesis by blocking the lengthening of factor G. Fusidic acid is active against staphylococcus epidermidis and methicillin resistant staphylococci.
	Read more about Fusidic acid
2	Betamethasone UNII 9IFA5XM7R2 - BETAMETHASONE VALERATE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07CC	Corticosteroids, potent, combinations with antibiotics	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics
Discover more medicines within D07CC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	5570-MEE-1020